EN DE
Watch TRUALT BIOENERGY LIMITED for free: we tell you when fair value or trend changes.
Data-driven stock valuation

TRUALT BIOENERGY LIMITED (TRUALT) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of TRUALT BIOENERGY LIMITED stock ₹158, price ₹340, that is 53.4% below the price, quality 28 out of 100. Rating: strongly overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Energy IN

TB TRUALT BIOENERGY LIMITED logo Some data Nov 14, 2026

TRUALT BIOENERGY LIMITED

TRUALT · NSE

Far too expensive (fair value 53% below the price), weak company and price moving sideways: meets none of the 3 rules.

Get notified free when this changes
Price moving sideways (no uptrend) 
Expensive Growth (revenue 3y +14.2 %/yr in INR) 
Thin margins · 8.1% net margin (TTM) 
Moderate debt 
Some data 
Fair value ₹158.15 · Strongly overvalued 
Quality 28/100 
Negative free cash flow 
Trails peers (4/12) 
Narrow moat 42/100 · thin data
⟳ Cyclical⚠ Small free float
Watch TRUALT BIOENERGY LIMITED for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

₹531.95 ₹319.65 Fair Value ₹158.15 Oct 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.

How to read this chart

13‑month range ₹319.65 – ₹531.95 · fair‑value band ₹138.56 – ₹197.69 · the ₹339.50 price screens above the ₹158.15 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.

Follow TRUALT BIOENERGY in your weekly email

Every Wednesday you see whether TRUALT BIOENERGY is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022.

Show moreShow less

TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.

Stock analysis

TRUALT BIOENERGY LIMITED (TRUALT) currently trades at ₹339.50, while our model-based Fair Value estimate is ₹158.15, 53% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of ₹197.94 per share, and 1 of the 14 models we run sit above the ₹339.50 price.

Bear case: the Economic Profit group reads lowest at ₹74.99, and 13 of the 14 models stay below the price. Data coverage for this calculation is medium.

Scenario range: ₹138.56 (bear) to ₹197.69 (bull), the price of ₹339.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 28/100 (below-average quality), in the Energy sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

TRUALT BIOENERGY LIMITED reported revenue of ₹17.3B in FY2026 versus ₹7.0B in FY2022, a compound +25.5%/yr. Reported net income was ₹969M in FY2026, compounding +26.7%/yr from FY2022.

Key figures

Market cap ₹29.0B (≈ $309M) Small · P/E ratio 13.2 · P/S ratio 1.06 · EPS (TTM) ₹25.77 · Net margin 8.1% · Return on equity 14.5% · Return on assets (EBIT) 6.7% (5-year average) · Operating margin 9.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).

What moves the price

The share trades about 36% below its 52-week high and 6% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Energy peers we cover trades at −47% fair-value upside, at −53%, TRUALT screens richer than that median.

Fair Value models

Bear ₹138.56 Fair Value ₹158.15 Bull ₹197.69
Price ₹339.50 · Downside -53.4%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 8 months old). Earnings retained since then (₹16.31 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
EPV ₹17.15 ₹30.38 ₹40.91 69
Residual Income ₹121.78 ₹119.59 ₹124.45 68
ROIC Compounder ₹17.15 ₹30.38 ₹40.91 67
All 14 models by family
Earnings-Based
Graham-Dodd ₹76.82 ₹410.45 ₹568.59 61
Lynch FV ₹113.31 ₹161.88 ₹210.44 58
PEG = 1.0 ₹113.31 ₹161.88 ₹210.44 55
EPV ₹17.15 ₹30.38 ₹40.91 69
Multiples
P/E Multiple ₹118.61 ₹158.15 ₹197.69 63
P/S Multiple ₹144.03 ₹192.04 ₹240.05 58
P/B Multiple ₹219.20 ₹292.26 ₹365.33 55
EV/EBIT n/a ₹55.72 ₹115.05 61
EV/EBITDA n/a ₹21.11 ₹71.80 62
EV/Revenue n/a ₹60.12 ₹132.64 50
Asset-Based
NCAV (Graham) ₹81.18 ₹108.79 ₹162.37 54
Economic Profit
Residual Income ₹121.78 ₹119.59 ₹124.45 68
ROIC Compounder ₹17.15 ₹30.38 ₹40.91 67
Growth Earnings
Growth-Adj P/E ₹138.56 ₹197.94 ₹257.33 65

Open the full fair value analysis →

Quality Score breakdown

Overall quality 28/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 31
Are margins and returns getting better?
Cashflow 0
Do the profits arrive as real cash?
Financial strength 31
Debt, balance sheet and risk of trouble
Investment 0
Does it invest with discipline instead of growing at any price?
Low Volatility 46
How calm the share price moves, does not count
Price momentum 16
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 6
Distance to the 52-week high, does not count
New shares 80
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 51/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−9.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.2%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
13.1% (2022) → 11.8% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 2 usable fiscal years, at least 4 required
not computed

TRUALT screens overvalued: fair value 53% below the price. Compare with Reliance Industries Limited →

Compare TRUALT BIOENERGY LIMITED with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Oil & Gas Refining & Marketing · 120 stocks

Beats the industry median on 4/12 measures
Overall it trails its industry peers.
Valuation
Quality Score 28 · Bottom 25%
Fair Value upside −53.4% · Bottom 25%
Profitability
Return on equity (12 months) 14.5% · Above median
Return on assets 2.6% · Below median
Net margin (12 months) 8.1% · Above median
Operating margin (12 months) 9.5% · Above median
Growth and dividend
Revenue growth (quarter YoY) 606.2% · Top 25%
Balance sheet
Debt / equity 0.65× · Above median

Valuation Multiplesvs Oil & Gas Refining & Marketing median · lower = cheaper

P/E (12 months) 13.2× · Pricier than median
P/B 1.91× · Pricier than median
P/S (12 months) 1.06× · Priciest 25%
EV/EBITDA 7.8× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 31
FUTURE (revenue growth)100 · sector 100
PAST (return on equity)58 · sector 48
HEALTH (low debt)68 · sector 85
DIVIDEND (yield)0 · sector 66

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Oil & gas

Similar stocks

10 more Oil & Gas Refining & Marketing stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Indian Oil Corporation IOC ₹144.03 ₹245.43 +70% vs TRUALT
Bharat Petroleum Corporation BPCL ₹305.30 ₹434.58 +42% vs TRUALT
SK Innovation Co 096770 106,900 KRW 116,828 KRW +9% vs TRUALT
Reliance Industries Limited RELIANCE ₹1,345 ₹865.31 −36% vs TRUALT
HF Sinclair Corporation DINO $99.05 $52.92 −47% vs TRUALT
Neste Oyj NESTE €27.15 €11.70 −57% vs TRUALT
Marathon Petroleum Corporation MPC $402.19 $172.57 −57% vs TRUALT
Formosa Petrochemical Corporation 6505 89.60 TWD 35.53 TWD −60% vs TRUALT
Valero Energy Corporation VLO $369.73 $131.30 −64% vs TRUALT
Phillips 66 PSX $260.62 $90.80 −65% vs TRUALT

Explore undervalued stocks

More undervalued Energy stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

TRUALT BIOENERGY LIMITED: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "TRUALT BIOENERGY LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/TRUALT

Frequently asked questions

Is TRUALT BIOENERGY LIMITED (TRUALT) overvalued or undervalued?
As of Nov 14, 2026, our model estimates a fair value of ₹158.15 versus a price of ₹339.50, about 53% lower (overvalued).
What is the fair value of TRUALT?
Our model-based fair value for TRUALT BIOENERGY LIMITED is ₹158.15 (as of Nov 14, 2026), built from audited fundamentals. The current price: ₹339.50.
What is the quality score of TRUALT?
TRUALT BIOENERGY LIMITED has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for TRUALT BIOENERGY LIMITED (TRUALT)?
Our model-based price target is the fair value of ₹158.15 (as of Nov 14, 2026) from 14 valuation models. Cautious scenario ₹138.56, optimistic scenario ₹197.69. It is a calculation from audited fundamentals, not an analyst target.
What is the TRUALT BIOENERGY LIMITED stock forecast for 2026?
Our models put fair value at ₹158.15, about 53% lower versus a price of ₹339.50 (overvalued). Cautious scenario ₹138.56, optimistic scenario ₹197.69. The calculation is refreshed regularly with new filings.
What is the revenue of TRUALT BIOENERGY LIMITED (TRUALT)?
TRUALT BIOENERGY LIMITED reported trailing-twelve-month revenue of about ₹27.5B (latest available figure, as of Nov 14, 2026).
What is the intrinsic value of TRUALT BIOENERGY LIMITED (TRUALT)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For TRUALT BIOENERGY LIMITED it is ₹158.15 per share (as of Nov 14, 2026), against a price of ₹339.50. It is the blended result of 14 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is TRUALT BIOENERGY LIMITED stock overvalued or undervalued in 2026?
As of Nov 14, 2026, TRUALT trades above its calculated fair value: price ₹339.50, fair value ₹158.15, a gap of about −53% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of TRUALT?
No. The price is what the market pays today (₹339.50); the fair value is what the company's own numbers justify (₹158.15). For TRUALT BIOENERGY LIMITED the two are ₹181.35 per share apart. That gap is exactly why we show both numbers side by side.
How much is TRUALT BIOENERGY LIMITED worth?
The market values TRUALT BIOENERGY LIMITED at about ₹29.0B (market capitalisation, as of Nov 14, 2026). Per share that is ₹339.50; our models calculate a fair value of ₹158.15 per share.
What do the bullish and bearish scenarios say about TRUALT?
Our models span a range for TRUALT BIOENERGY LIMITED: cautious scenario ₹138.56, base ₹158.15, optimistic ₹197.69 per share (as of Nov 14, 2026, price ₹339.50). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of TRUALT?
TRUALT BIOENERGY LIMITED trades at a price-to-earnings ratio of 13.2 (as of Nov 14, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹158.15 is built from several models across several years. Other multiples: P/B 1.9, P/S 1.1, EV/EBITDA 7.8.
How solid is the balance sheet of TRUALT BIOENERGY LIMITED (TRUALT)?
Balance-sheet figures for TRUALT BIOENERGY LIMITED (as of Nov 14, 2026): return on equity 14.5%, debt of 0.65 per unit of equity. They feed the Quality Score of 28/100, which measures business quality independently of the share price.
How far is TRUALT from its 52-week high?
TRUALT BIOENERGY LIMITED trades at ₹339.50, about 36% below its 52-week high of ₹531.95 and 6% above the low of ₹319.65 (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of ₹158.15 is for.
Which stocks are comparable to TRUALT BIOENERGY LIMITED?
From the same area (Energy) we also value Reliance Industries Limited, Valero Energy Corporation, Phillips 66, Marathon Petroleum Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is TRUALT BIOENERGY LIMITED stock attractive at the current price?
The data as of Nov 14, 2026: price ₹339.50, calculated fair value ₹158.15 (−53%), Quality Score 28/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of TRUALT calculated?
We run TRUALT BIOENERGY LIMITED through 14 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of ₹158.15 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.6% above its aggregate fair value. TRUALT BIOENERGY LIMITED itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of TRUALT BIOENERGY LIMITED (TRUALT)?
The closing price on Nov 16, 2026 was ₹339.50. Our model-based fair value is ₹158.15, about 53% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with TRUALT BIOENERGY LIMITED right now?
The price sits above even our optimistic bull case (₹197.69). The favourable scenario is already priced in. Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts.

Key figures of TRUALT BIOENERGY LIMITED

How large is the market capitalisation of TRUALT BIOENERGY LIMITED (TRUALT)?
The market capitalisation of TRUALT BIOENERGY LIMITED is ₹29.0B (≈ $309M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of TRUALT BIOENERGY LIMITED (TRUALT)?
The price-to-sales ratio of TRUALT BIOENERGY LIMITED is 1.06 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of TRUALT BIOENERGY LIMITED (TRUALT)?
Earnings per share at TRUALT BIOENERGY LIMITED are ₹25.77 (price ÷ EPS = P/E 13.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of TRUALT BIOENERGY LIMITED (TRUALT)?
The net margin of TRUALT BIOENERGY LIMITED is 8.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of TRUALT BIOENERGY LIMITED (TRUALT)?
The return on equity (ROE) of TRUALT BIOENERGY LIMITED is 14.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of TRUALT BIOENERGY LIMITED (TRUALT)?
On an EBIT basis the return on assets of TRUALT BIOENERGY LIMITED is 6.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of TRUALT BIOENERGY LIMITED (TRUALT)?
The operating margin of TRUALT BIOENERGY LIMITED is 9.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at TRUALT BIOENERGY LIMITED (TRUALT)?
Revenue at TRUALT BIOENERGY LIMITED is growing 606% versus a year earlier (3y avg +14.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at TRUALT BIOENERGY LIMITED (TRUALT)?
Earnings per share at TRUALT BIOENERGY LIMITED are growing 896% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does TRUALT BIOENERGY LIMITED (TRUALT) generate?
The free cash flow of TRUALT BIOENERGY LIMITED is −₹8.1B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does TRUALT BIOENERGY LIMITED (TRUALT) carry?
The net debt of TRUALT BIOENERGY LIMITED is ₹15.6B (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch TRUALT BIOENERGY LIMITED in the live analysis

One click puts TRUALT BIOENERGY LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.